Vaxxinity Statistics

Total Valuation

Vaxxinity has a market cap or net worth of $25.35 million. The enterprise value is $10.02 million.

Market Cap	25.35M
Enterprise Value	10.02M

Important Dates

The next estimated earnings date is Tuesday, May 7, 2024, before market open.

Earnings Date	May 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Vaxxinity has 126.75 million shares outstanding. The number of shares has increased by 0.45% in one year.

Shares Outstanding	126.75M
Shares Change (YoY)	+0.45%
Shares Change (QoQ)	+0.38%
Owned by Insiders (%)	50.93%
Owned by Institutions (%)	12.30%
Float	55.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.89
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 1.13.

Current Ratio	1.89
Quick Ratio	n/a
Debt / Equity	1.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-80.80

Financial Efficiency

Return on equity (ROE) is -192.60% and return on invested capital (ROIC) is -203.96%.

Return on Equity (ROE)	-192.60%
Return on Assets (ROA)	-88.00%
Return on Capital (ROIC)	-203.96%
Revenue Per Employee	n/a
Profits Per Employee	-$998,842
Employee Count	57
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -89.19% in the last 52 weeks. The beta is 2.40, so Vaxxinity's price volatility has been higher than the market average.

Beta (1Y)	2.40
52-Week Price Change	-89.19%
50-Day Moving Average	0.65
200-Day Moving Average	1.20
Relative Strength Index (RSI)	19.05
Average Volume (30 Days)	540,322

Short Selling Information

The latest short interest is 4.08 million, so 3.22% of the outstanding shares have been sold short.

Short Interest	4.08M
Short Previous Month	3.85M
Short % of Shares Out	3.22%
Short % of Float	7.38%
Short Ratio (days to cover)	7.87

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-58.29M
Pretax Income	-56.93M
Net Income	-56.93M
EBITDA	-54.00M
EBIT	-56.24M
Earnings Per Share (EPS)	-$0.45

Full Income Statement

Balance Sheet

The company has $30.50 million in cash and $15.17 million in debt, giving a net cash position of $15.33 million or $0.12 per share.

Cash & Cash Equivalents	30.50M
Total Debt	15.17M
Net Cash	15.33M
Net Cash Per Share	$0.12
Equity / Book Value	13.41M
Book Value Per Share	0.11
Working Capital	15.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$57.24 million and capital expenditures -$803,000, giving a free cash flow of -$58.04 million.

Operating Cash Flow	-57.24M
Capital Expenditures	-803,000
Free Cash Flow	-58.04M
FCF Per Share	-$0.46

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Vaxxinity does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.45%
Shareholder Yield	-0.45%
Earnings Yield	-224.60%
FCF Yield	-228.96%

Analyst Forecast

The average price target for Vaxxinity is $7.00, which is 3,400.00% higher than the current price. The consensus rating is "Buy".

Price Target	$7.00
Price Target Difference	3,400.00%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-2.94%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a